Enzymotec wins Israeli phytosterol patent

Related tags Denmark European union New zealand

Israeli-based lipid specialist, Enzymotec, has been granted a home turf patent for the composition and production of its phytosterol ingredient, Cardiobeat.

The patent follows previous approvals granted in China and New Zealand as well as new dietary ingredient status in the US and novel food approval in the European Union.

Further process and efficacy patents are pending in other international jurisdictions.

CardiaBeat, derived from an omega-3 glyceride matrix, has been shown to reduce the likelihood of cardiovascular disease in clinical trials.

Related news

Show more

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 08-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Sweetening solution for active nutrition

Sweetening solution for active nutrition

Content provided by ADM | 19-Feb-2024 | Case Study

When you add GrainSweet® Liquid Maltodextrin to your active nutrition applications, you get the production efficiencies, clean labels, and clean tastes...

Nutritional Solutions for Women's Health

Nutritional Solutions for Women's Health

Content provided by INNOBIO Corporation Limited | 04-Oct-2023 | White Paper

INNOBIO provides innovative solutions for women to overcome a variety of health challenges throughout the life cycle, from emotional health, PMS management,...

Related suppliers

Follow us

Products

View more

Webinars